Drug and psychosocial curricula for psychiatry residents for treatment of schizophrenia: part I.
Liberman
Robert Paul
RP
Neuropsychiatric Institute, University of California-Los Angeles, 760 Westwood Plaza, Los Angeles, CA 90095, USA. rpl@ucla.edu
Glick
Ira D
ID
D019090:Case Management / Q000458:organization & administration; D003479:Curriculum / Q000592:standards; D019317:Evidence-Based Medicine; D019983:Guideline Adherence; D006801:Humans; D007396:Internship and Residency / Q000458:organization & administration*; D008508:Medication Errors; D017410:Practice Guidelines as Topic; D011570:Psychiatry / Q000193:education*; D011600:Psychopharmacology / Q000193:education*; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*; D011785:Quality Assurance, Health Care / Q000458:organization & administration; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D012949:Social Work, Psychiatric / Q000193:education*; D014481:United States
D011619:Psychotropic Drugs